Ian M. Burr Division of Pediatric Endocrinology and Diabetes

September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

By VUMC News and Communications

June 13, 2013

New protocol takes the sting out of Children’s Hospital outpatient procedures

A patient comfort protocol is rendering minor procedures less painful and upsetting for younger outpatients of the Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Paul Govern

May 9, 2013

Russell’s diabetes treatment efforts honored

The Middle Tennessee Chapter of the Juvenile Diabetes Research Foundation (JDRF) has awarded Vanderbilt’s William Russell, M.D., professor of Pediatrics and director of the division of Pediatric Endocrinology and Diabetes, its highest honor — the Living and Giving Award for support of people diagnosed with type 1 diabetes (T1D).

By VUMC News and Communications

April 11, 2013

Therapy helps regenerate child’s undeveloped bones

Janelly Martinez-Amador was born with thin, fragile bones, and by 3, she had no visible bones on X-rays. Initially, doctors weren’t sure she would survive her first birthday.

By Christina Echegaray

August 30, 2012

Diabetes can’t hold back Little League champion

By Christina Echegaray

July 31, 2012

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.

By Craig Boerner